Literature DB >> 27146545

Popular pharmaceutical residues in hospital wastewater: quantification and qualification of degradation products by mass spectroscopy after treatment with membrane bioreactor.

M Chiarello1,2, L Minetto1, S V Della Giustina2, L L Beal2, S Moura3.   

Abstract

The occurrence of drugs in wastewater has been considered an imminent risk to the population, for the treatments used are usually ineffective. The presence of four popular drug residues (metformin, paracetamol, tetracycline, and enalapril) in hospital effluents, by using ultra-fast liquid chromatography tandem mass spectrometry (UFLC-MS/MS) with electrospray (ESI) ionization, and removal/degradation by membrane bioreactor (MBR) system are investigated in this study. For analysis method, all standard calibration curves showed satisfactory linearity (R (2) ≥ 0.993) within a relatively wide range. The recovery was between 70.4 and 105.0 %, and the relative standard deviation (RSD) values were within the ranges of 8.2 and 13.5 %. The effluent samples were collected at the end of the process treated in a bench-scale MBR treatment system and preconcentrated on solid-phase extraction (SPE) cartridges. Following that procedure, the chemical analysis demonstrated that the MBR system was effective in enalapril 94.3 ± 7.63 %, tetracycline 99.4 ± 0.02 %, and paracetamol 98.8 ± 0.86 % removal. However, the polar metformin was less effectively removed (35.4 ± 12.49 %). Moreover, the degradation products were investigated using high-resolution mass spectrometry (HRMS) by quadrupole-time of flight (Q-TOF), which has been indicated a tetracycline metabolite. In order to investigate the environmental impact, the wastewater potential risk was evaluated. The risk quotient (RQ) by measure environmental concentration (MEC) and its predicted no effect concentration (PNEC) ratio (RQ = MEC/PNEC) was between 0.003 (enalapril) to 0.815 (paracetamol). Finally, this work demonstrates that UFLC-MS/MS (ESI-Q) is a sensitive and selective method for drug analysis in wastewater and with ESI-Q-TOF has the accuracy required for determining the degradation products of these compounds. Also, it indicated that membrane bioreactor systems represent a new generation of processes that have proved to outperform conventional treatment showing better effluent quality. The removal capacity studied in this work demonstrates the efficiency of this process.

Entities:  

Keywords:  Degradation product; Hospital effluent; Mass spectrometry; Membrane bioreactor; Pharmaceutical residues

Mesh:

Substances:

Year:  2016        PMID: 27146545     DOI: 10.1007/s11356-016-6766-2

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  47 in total

1.  Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data.

Authors:  Thomas Heberer
Journal:  Toxicol Lett       Date:  2002-05-10       Impact factor: 4.372

2.  Comparison between the conventional anaerobic digestion of sewage sludge and its combination with a chemical or thermal pre-treatment concerning the removal of pharmaceuticals and personal care products.

Authors:  M Carballa; F Omil; A C Alder; J M Lema
Journal:  Water Sci Technol       Date:  2006       Impact factor: 1.915

3.  Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments.

Authors:  M D Hernando; M Mezcua; A R Fernández-Alba; D Barceló
Journal:  Talanta       Date:  2005-11-18       Impact factor: 6.057

4.  Removal of trace organics by MBR treatment: the role of molecular properties.

Authors:  Nichanan Tadkaew; Faisal I Hai; James A McDonald; Stuart J Khan; Long D Nghiem
Journal:  Water Res       Date:  2011-04       Impact factor: 11.236

5.  Effects of ozone and ozone/peroxide on trace organic contaminants and NDMA in drinking water and water reuse applications.

Authors:  Aleksey N Pisarenko; Benjamin D Stanford; Dongxu Yan; Daniel Gerrity; Shane A Snyder
Journal:  Water Res       Date:  2011-10-25       Impact factor: 11.236

Review 6.  Liquid chromatography-tandem mass spectrometry for the analysis of pharmaceutical residues in environmental samples: a review.

Authors:  Mira Petrović; Maria Dolores Hernando; M Silvia Díaz-Cruz; Damià Barceló
Journal:  J Chromatogr A       Date:  2005-03-04       Impact factor: 4.759

7.  Characterization of Pharmaceuticals and Personal Care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS.

Authors:  Tiago S Oliveira; Mark Murphy; Nicholas Mendola; Virginia Wong; Doreen Carlson; Linda Waring
Journal:  Sci Total Environ       Date:  2015-03-13       Impact factor: 7.963

8.  Pre-treatment of hospital wastewater by coagulation-flocculation and flotation.

Authors:  Sonia Suarez; Juan M Lema; Francisco Omil
Journal:  Bioresour Technol       Date:  2008-12-23       Impact factor: 9.642

9.  Determination of 76 pharmaceutical drugs by liquid chromatography-tandem mass spectrometry in slaughterhouse wastewater.

Authors:  Bing Shao; Dong Chen; Jing Zhang; Yongning Wu; Chengjun Sun
Journal:  J Chromatogr A       Date:  2009-08-21       Impact factor: 4.759

10.  Investigating the removal of some pharmaceutical compounds in hospital wastewater treatment plants operating in Saudi Arabia.

Authors:  Hamed Al Qarni; Philip Collier; Juliette O'Keeffe; Joseph Akunna
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-21       Impact factor: 4.223

View more
  2 in total

1.  Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.

Authors:  Gabrielle Rabelo Quadra; Helena Oliveira de Souza; Rafaela Dos Santos Costa; Marcos Antonio Dos Santos Fernandez
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-13       Impact factor: 4.223

Review 2.  Organic micropollutants paracetamol and ibuprofen-toxicity, biodegradation, and genetic background of their utilization by bacteria.

Authors:  Joanna Żur; Artur Piński; Ariel Marchlewicz; Katarzyna Hupert-Kocurek; Danuta Wojcieszyńska; Urszula Guzik
Journal:  Environ Sci Pollut Res Int       Date:  2018-06-19       Impact factor: 4.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.